Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gekeler

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Cancer Letters|February 6, 1996
Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodiesJ Beck, V Gekeler, M Ringger, et al.
The Journal of Biological Chemistry|February 15, 1987
A human purine nucleoside phosphorylase deficiency caused by a single base changeS R Williams, V Gekeler, R S McIvor, et al.
British Journal of Pharmacology|April 29, 1998
Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferationF Gantner, C Götz, V Gekeler, et al.
Leukemia Research|December 24, 1997
A novel method for direct and fluorescence independent determination of drug efflux out of leukemic blast cellsM Schaich, S Neu, J Beck, et al.
British Journal of Haematology|February 1, 1995
Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemiasJ Beck, R Handgretinger, R Dopfer, et al.
Biochemical and Biophysical Research Communications|March 8, 1995
The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistanceV Gekeler, W Ise, K H Sanders, et al.
The Journal of Allergy and Clinical Immunology|October 24, 1997
Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative studyF Gantner, H Tenor, V Gekeler, et al.
Biochemical and Biophysical Research Communications|January 5, 1995
The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistanceV Gekeler, R Boer, W Ise, et al.
Molecular Pharmacology|June 1, 1996
Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistanceP Chiba, G Ecker, D Schmid, et al.
European Journal of Pharmacology|December 15, 1994
Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cellsJ Malkhandi, D R Ferry, R Boer, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cancer Letters|February 6, 1996
Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodiesJ Beck, V Gekeler, M Ringger, et al.
The Journal of Biological Chemistry|February 15, 1987
A human purine nucleoside phosphorylase deficiency caused by a single base changeS R Williams, V Gekeler, R S McIvor, et al.
British Journal of Pharmacology|April 29, 1998
Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferationF Gantner, C Götz, V Gekeler, et al.
Leukemia Research|December 24, 1997
A novel method for direct and fluorescence independent determination of drug efflux out of leukemic blast cellsM Schaich, S Neu, J Beck, et al.
British Journal of Haematology|February 1, 1995
Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemiasJ Beck, R Handgretinger, R Dopfer, et al.
Biochemical and Biophysical Research Communications|March 8, 1995
The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistanceV Gekeler, W Ise, K H Sanders, et al.
The Journal of Allergy and Clinical Immunology|October 24, 1997
Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative studyF Gantner, H Tenor, V Gekeler, et al.
Biochemical and Biophysical Research Communications|January 5, 1995
The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistanceV Gekeler, R Boer, W Ise, et al.
Molecular Pharmacology|June 1, 1996
Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistanceP Chiba, G Ecker, D Schmid, et al.
European Journal of Pharmacology|December 15, 1994
Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cellsJ Malkhandi, D R Ferry, R Boer, et al.
Pageof 6